Regeneron Pharma revenue rises 37 pct
Wednesday, February 10, 2016
Regeneron Pharmaceuticals Inc reported a 37 percent rise in quarterly revenue as sales of its blockbuster eye drug Eylea increased 44 percent in the United States.
Net income rose to $155 million, or $1.34 per share, for the fourth quarter ended Dec. 31, from $90 million, or 78 cents per share, a year earlier.
Revenue rose to $1.10 billion from $802 million.
reuters.com
